952 related articles for article (PubMed ID: 35180475)
1. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
3. [Effect and mechanism of Jiedu Huoxue Decoction in regulating YAP/ACSL4 pathway to inhibit ferroptosis in treatment of acute kidney injury].
Cheng R; Tian RM; Huang LH; Wang XW; Guo S; Wu AJ; Li C; Chen J; Li SJ; Chen M; Mao W; Xu P
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):151-161. PubMed ID: 38403348
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4
Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH
Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574
[TBL] [Abstract][Full Text] [Related]
5. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
6. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
[TBL] [Abstract][Full Text] [Related]
7. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.
Cui Y; Zhang Y; Zhao X; Shao L; Liu G; Sun C; Xu R; Zhang Z
Brain Behav Immun; 2021 Mar; 93():312-321. PubMed ID: 33444733
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into the protective effects of leonurine against acute kidney injury: Inhibition of ER stress-associated ferroptosis via regulating ATF4/CHOP/ACSL4 pathway.
Cheng R; Wang X; Huang L; Lu Z; Wu A; Guo S; Li C; Mao W; Xie Y; Xu P; Tian R
Chem Biol Interact; 2024 May; 395():111016. PubMed ID: 38670420
[TBL] [Abstract][Full Text] [Related]
9. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis.
Sun Z; Wu J; Bi Q; Wang W
Stem Cell Res Ther; 2022 Jul; 13(1):297. PubMed ID: 35841017
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
Dai Y; Chen Y; Mo D; Jin R; Huang Y; Zhang L; Zhang C; Gao H; Yan Q
Commun Biol; 2023 Sep; 6(1):907. PubMed ID: 37670055
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic HMGB1 induces renal tubular ferroptosis after ischemia/reperfusion.
Zhao Z; Li G; Wang Y; Li Y; Xu H; Liu W; Hao W; Yao Y; Zeng R
Int Immunopharmacol; 2023 Mar; 116():109757. PubMed ID: 36731154
[TBL] [Abstract][Full Text] [Related]
12. MitoQ protects against carbon tetrachloride-induced hepatocyte ferroptosis and acute liver injury by suppressing mtROS-mediated ACSL4 upregulation.
Tao L; Xue YF; Sun FF; He X; Wang HQ; Tong CC; Zhang C; Xu DX; Chen X
Toxicol Appl Pharmacol; 2024 May; 486():116914. PubMed ID: 38522585
[TBL] [Abstract][Full Text] [Related]
13. Loss of nephric augmenter of liver regeneration facilitates acute kidney injury via ACSL4-mediated ferroptosis.
Huang L; Zhang L; Zhang Z; Tan F; Ma Y; Zeng X; Cao D; Deng L; Liu Q; Sun H; Shen B; Liao X
J Cell Mol Med; 2024 Feb; 28(3):e18076. PubMed ID: 38088220
[TBL] [Abstract][Full Text] [Related]
14. MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis.
Shi L; Song Z; Li Y; Huang J; Zhao F; Luo Y; Wang J; Deng F; Shadekejiang H; Zhang M; Dong S; Wu X; Zhu J
Am J Transplant; 2023 Jan; 23(1):11-25. PubMed ID: 36695612
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone inhibits acyl-CoA synthetase long-chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury.
Shen J; Qian M; Wu M; Tang J; Gong Y; Li J; Ji J; Dang B
Clin Exp Pharmacol Physiol; 2023 Dec; 50(12):927-935. PubMed ID: 37675456
[TBL] [Abstract][Full Text] [Related]
16. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
[TBL] [Abstract][Full Text] [Related]
17. Enriched Environment Attenuates Ferroptosis after Cerebral Ischemia/Reperfusion Injury via the HIF-1
Liu J; Luo Q; Ke J; Zhang D; Xu Y; Liao W; Chen X; Zhang X
Oxid Med Cell Longev; 2023; 2023():5157417. PubMed ID: 36819784
[TBL] [Abstract][Full Text] [Related]
18. ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model.
Cao D; Zheng J; Li Z; Yu Y; Chen Z; Wang Q
Arthritis Res Ther; 2023 Oct; 25(1):212. PubMed ID: 37884942
[TBL] [Abstract][Full Text] [Related]
19. Penehyclidine Hydrochloride Improves Rhabdomyolysis-Mediated Acute Kidney Injury by Inhibiting Ferroptosis through the HIF-1α/MT1G Axis.
Chen L; Luo S; Tan H
Nephron; 2024; 148(5):333-344. PubMed ID: 37839409
[TBL] [Abstract][Full Text] [Related]
20. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
